Journal profile · Agricultural and Biological Sciences-Food Science

Onco

ISSN 2673-7523 · MDPI AG · Switzerland

Onco: impact factor 2 (journal website); fully open access; APC charged, amount not published; review about 6 weeks (community reports); 55 articles in 2025; indexed in Scopus.

Impact factor2From the journal's website, latest value
CAS zone—Not in the CAS Journal Ranking
Review timeabout 6 weeksCommunity average
APCCharged, amount not publishedFully open access
Acceptance—No reports yet
Articles per year552025 · OpenAlex count

Scope

Aims, scope and focus

Onco is published by MDPI AG. By OpenAlex counts of its recent articles, its largest topics are Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics and Cancer, Hypoxia, and Metabolism, together about 24.2% of its articles. Its main subfields are Oncology. (generated from OpenAlex topic counts and CAS ranking data)

AimsOnco (ISSN 2673-7523) is a peer-reviewed Open Access journal on oncotargets and cancer therapies, published online by MDPI. It publishes article types including Research Papers, Reviews, Editorials, Communications, etc. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The full experimental details must be provided so that the results can be reproduced.ScopeOnco functions as a scientific forum to integrate novel preclinical, translational and clinical cancer research with a primary focus on oncotargets and cancer therapies. The journal invites submissions of original research, reviews, editorials and commentaries covering a broad range of scientific domains, including (but not limited to): Cancer cell signaling; Cancer genetics and molecular targets; Cancer epigenetics and heterogeneity; Carcinogenesis and cancer evolution; Microbiome and cancer; Cancer metabolomics; Cancer biomarkers; Cancer dormancy; Novel targeted and immune cancer therapies; Randomized clinical trials; Oncotargets; Cancer therapies; Clinical reports proposing novel therapeutic regimens. Short reports can be considered, provided that they present a clear relationship with one or more of the above topics.Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. The experimental details must be provided so that the results can be reproduced.Onco’s Editorial Board, consisting of international experts from leading institutions, oncology centers and universities in cancer research, aims to promote the evolving field of oncology.MDPI Publication Ethics Statement MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.Book ReviewsAuthors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as

From the journal's Aims & Scope

Research area (LetPub): Agricultural and Biological Sciences-Food Science

Editorial board by country: none in mainland China; most named United States 5, Germany 5, Italy 5, France 4, Greece 4 (31 members with a country) Editorial board ↗Publisher website ·

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Cancer Immunotherapy and BiomarkersMedicine9.7%
  2. Cancer Genomics and DiagnosticsBiochemistry, Genetics and Molecular Biology8.2%
  3. Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology6.3%
  4. Glioma Diagnosis and TreatmentMedicine5.8%
  5. Lung Cancer Treatments and MutationsMedicine5.3%
  6. Immunotherapy and Immune ResponsesImmunology and Microbiology5.3%
  7. Cancer Cells and MetastasisMedicine4.4%
  8. Lung Cancer Research StudiesMedicine4.4%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Indexing the journal's website claims

ESCIWeb of SciencePublisher website

As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

Impact factor (publisher)
2Publisher website ·
CiteScore 2026-06
2LetPub ·
CiteScore (publisher)
2Publisher website ·
SJR 2026-06
0.32LetPub ·
SNIP 2026-06
0.29LetPub ·
h-index
9OpenAlex ·
i10-index
8OpenAlex ·
2-year mean citedness
2.08OpenAlex ·
Share of gold OA articles
0%LetPub ·

Volume

Articles per year (publisher)
2,022Publisher website ·

Articles by year OpenAlex count · 191 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026464613
20255555141
20243232123
2023161674
2022171764
2021171768

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 6 weeksLetPub ·
Submission to first decision
16.4 daysPublisher website ·
Acceptance to publication
4.5 daysPublisher website ·
Submission to publication (journal-reported)
about 6 weeksDOAJ ·
Peer review
Single anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJCHF 1,000YesCC BY
OpenAlexCHF 1,000——
LetPubCHF 1,000Yes—
Publisher websiteYes, amount not published——

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

Open calls for papers1, by deadline
  1. Biomarkers for the Detection of Cancer and Monitoring Response to TreatmentDeadline
Publisher website
Article types accepted20
  1. articleArticle: These are original research manuscripts.Length not stated
  2. book reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  3. brief communicationAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  4. brief reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  5. case reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  6. commentaryAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  7. conference reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  8. editorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  9. hypothesisAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  10. letterAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  11. opinionAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  12. perspectiveAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  13. protocolAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  14. registered reportAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  15. reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  16. scoping reviewA Scoping Review type can be submitted as a Review.Length not stated
  17. systematic reviewAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  18. technical noteAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  19. tutorialAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
  20. viewpointAll Article Types Article Review Communication Editorial Abstract Book Review Brief Communication Brief Report Case Report Clinicopathological Challenge Comment…Length not stated
Publisher website
Policy excerpts from the journal's websiteAuthorship, Code availability, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
Authorship Authorship

MDPI follows the International Committee of Medical Journal Editors (ICMJE) guidelines which state that, in order to qualify for authorship of a manuscript, the following criteria should be observed: Make substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data for the work; Draft the work or review it critically for important intel…

Source ↗Publisher website ·
Code availability

Citation policy. Model summary

Authors should ensure that where material is taken from other sources (including their own published writing) the source is clearly cited and that where appropriate permission is obtained.

Source ↗Publisher website ·
Conflicts of interest Conflicts of Interest

According to The International Committee of Medical Journal Editors, “Authors should avoid entering into agreements with study sponsors, both for-profit and non-profit, that interfere with authors’ access to all of the study’s data or that interfere with their ability to analyze and interpret the data and to prepare and publish manuscripts independently when and where they choose.” All authors mus…

Source ↗Publisher website ·
Data availability Data availability statements

Data sharing and archiving policy. Model summary

Data availability statements are required for all articles published with MDPI. During the peer review and editorial decision process, authors can be asked to share existing datasets or raw data that have been analyzed in the manuscript, and whether they will be made available to other researchers following publication. Authors will also be asked for the details of any existing datasets that have …

Source ↗Publisher website ·
Publication ethics Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines. The editors of this journal enforce a rigorous peer review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification,…

Source ↗Publisher website ·
License & copyright Copyright / Open Access

Articles published in Onco will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and condi…

Source ↗Publisher website ·
Open access Open access publication fees

Open access licensing for all articles. Model summary

If you transfer your manuscript to another open access (OA) journal, you will be charged an Article Processing Charge (APC) if your article is accepted for publication. The APC for each journal can be found on the individual journal’s website. For more information about APCs, please see here.

Source ↗Publisher website ·
Peer review Editorial Process and Peer Review

Feature papers are invited submissions of advanced research. Model summary

All submissions are thoroughly peer-reviewed by experts within the field and undergo a structured editorial workflow designed to ensure quality, transparency, and scientific integrity. The full editorial procedure is available on the Editorial Process page and is also provided below. Pre-check Pre-check consists of a technical pre-check performed by the Editorial Office and an editorial pre-check …

Source ↗Publisher website ·
Preprints Preprints and Conference Papers

Onco accepts submissions that have previously been made available as preprints provided that they have not undergone peer review. A preprint is a draft version of a paper made available online before submission to a journal. MDPI operates Preprints, a preprint server to which submitted papers can be uploaded directly after completing journal submission. Note that Preprints operates independently o…

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
MDPI AG
Country or region
Switzerland
Language
English
ISSN
2673-7523
Latest issue on the website
Volume 6 (2026)
Official links

FAQ

Frequently asked questions about Onco

What is the impact factor of Onco?

The journal's website gives an impact factor of 2; this is the journal's own figure, as LetPub lists none for it; CiteScore 2, h-index 9.

How long does peer review take at Onco?

Authors report an average review time of about 6 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Onco based?

Of the 31 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (5), Germany (5) and Italy (5). Counted from the institutions listed on the board page; for reference only.

Which databases index Onco?

According to LetPub and DOAJ records, Onco is indexed in Scopus and DOAJ. The journal's website also lists ESCI and Web of Science; that list has not been checked against each database.

Is Onco open access, and what is the APC?

Onco is a fully open-access journal. APC charged, amount not published.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .